 | Up a level |
Sun, Dan-Qin and Targher, Giovanni and Byrne, Christopher D. and Wheeler, David C. and Wong, Vincent Wai-Sun and Fan, Jian-Gao and Tilg, Herbert and Yuan, Wei-Jie and Wanner, Christoph and Gao, Xin and Long, Michelle T. and Kanbay, Mehmet and Nguyen, Mindie H. and Navaneethan, Sankar D. and Yilmaz, Yusuf and Huang, Yuli and Gani, Rino A. and Marzuillo, Pierluigi and Boursier, Jerome and Zhang, Huijie and Jung, Chan-Young and Chai, Jin and Valenti, Luca and Papatheodoridis, George and Musso, Giovanni and Wong, Yu-Jun and El-Kassas, Mohamed and Mendez-Sanchez, Nahum and Sookoian, Silvia and Pavlides, Michael and Duseja, Ajay and Holleboom, Adriaan G. and Shi, Junping and Chan, Wah-Kheong and Fouad, Yasser and Yang, Junwei and Treeprasertsuk, Sombat and Cortez-Pinto, Helena and Hamaguchi, Masahide and Romero-Gomez, Manuel and Al Mahtab, Mamun and Ocama, Ponsiano and Nakajima, Atsushi and Dai, Chunsun and Eslam, Mohammed and Wei, Lai and George, Jacob and Zheng, Ming-Hua (2023) An international Delphi consensus statement on metabolic dysfunction-associated fatty liver disease and risk of chronic kidney disease. Hepatobiliary Surgery and Nutrition, 12 (3). 386+. ISSN 2304-3881, DOI https://doi.org/10.21037/hbsn-22-421.
Lau, George and Yu, Ming-Lung and Wong, Grace and Thompson, Alexander and Ghazinian, Hasmik and Hou, Jin-Lin and Piratvisuth, Teerha and Jia, Ji-Dong and Mizokami, Masashi and Cheng, Gregory and Chen, Guo-Feng and Liu, Zhen-Wen and Baatarkhuu, Oidov and Cheng, Ann Lii and Ng, Woon Leung and Lau, Patrick and Mok, Tony and Chang, Jer-Ming and Hamid, Saeed and Dokmeci, A. Kadir and Gani, Rino A. and Payawal, Diana A. and Chow, Pierce and Park, Joong-Won and Strasser, Simone and Mohamed, Rosmawaiti and Win, Khin Maung and Tawesak, Tanwandee and Sarin, Shiv Kumar and Omata, Masao (2021) APASL clinical practice guideline on hepatitis B reactivation related to the use of immunosuppressive therapy. Hepatology International, 15 (5). pp. 1031-1048. ISSN 1936-0533, DOI https://doi.org/10.1007/s12072-021-10239-x.
